EGRX

Eagle Pharmaceuticals, Inc.

Delisted

EGRX was delisted on the 2nd of October, 2024.

149 hedge funds and large institutions have $1.31B invested in Eagle Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 48 increasing their positions, 46 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
149
Holders Change
+12
Holders Change %
+8.76%
% of All Funds
3.73%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.15%
New
31
Increased
48
Reduced
46
Closed
16
Calls
$20.7M
Puts
$18.4M
Net Calls
+$2.23M
Net Calls Change
-$8.96M
Name Holding Trade Value Shares
Change
Shares
Change %
Asset Management One
151
Asset Management One
Japan
-$6.28M -89,729 Closed
Capital Fund Management (CFM)
152
Capital Fund Management (CFM)
France
-$5.77M -82,415 Closed
WSA
153
Wall Street Associates
California
-$2.46M -35,200 Closed
American Century Companies
154
American Century Companies
Missouri
-$1.92M -27,425 Closed
AA
155
ALPS Advisors
Colorado
-$1.4M -19,933 Closed
VKH
156
Virtu KCG Holdings
New York
-$642K -9,175 Closed
Squarepoint
157
Squarepoint
New York
-$628K -8,971 Closed
SC
158
Sculptor Capital
New York
-$406K -5,800 Closed
LSCM
159
LaSalle Street Capital Management
Illinois
-$299K -4,278 Closed
UBS AM
160
UBS AM
Illinois
-$245K -3,500 Closed
BFM
161
Boothbay Fund Management
New York
-$220K -3,146 Closed
BCM
162
Bayesian Capital Management
New York
-$212K -3,032 Closed
MWP
163
MYCIO Wealth Partners
Pennsylvania
-$2K -22 Closed
Creative Planning
164
Creative Planning
Kansas
-$1K -16 Closed